TP53 and non-small cell lung carcinoma: It has also been reported that in non-small-cell lung cancer and prostate cancer cells, p53 expression induces apoptosis and enhances chemotherapeutic cytotoxic effects of docetaxel which is in agreement with our findings (31, 32).